* Secondary source (Wikidata) — verify before on-air use
Sources: Office of the Clerk, U.S. House — MemberData.xml (published 2026-10-01)؛ Contact page on the member's official .gov site (verified HTTP 200)
Sources: congress-legislators — legislators-district-offices
Sources: congress-legislators — committees-current + committee-membership-current
| Chamber | From | To | State/District | Party | Congress |
|---|---|---|---|---|---|
| House | Jan 3, 2025 | Jan 3, 2027 | CO-1 | Democrat | 119 |
| House | Jan 3, 2023 | Jan 3, 2025 | CO-1 | Democrat | 118 |
| House | Jan 3, 2021 | Jan 3, 2023 | CO-1 | Democrat | 117 |
| House | Jan 3, 2019 | Jan 3, 2021 | CO-1 | Democrat | 116 |
| House | Jan 3, 2017 | Jan 3, 2019 | CO-1 | Democrat | 115 |
| House | Jan 6, 2015 | Jan 3, 2017 | CO-1 | Democrat | 114 |
| House | Jan 3, 2013 | Jan 3, 2015 | CO-1 | Democrat | 113 |
| House | Jan 5, 2011 | Jan 3, 2013 | CO-1 | Democrat | 112 |
| House | Jan 6, 2009 | Jan 3, 2011 | CO-1 | Democrat | 111 |
| House | Jan 4, 2007 | Jan 3, 2009 | CO-1 | Democrat | 110 |
| House | Jan 4, 2005 | Jan 3, 2007 | CO-1 | Democrat | 109 |
| House | Jan 7, 2003 | Jan 3, 2005 | CO-1 | Democrat | 108 |
| House | Jan 3, 2001 | Jan 3, 2003 | CO-1 | Democrat | 107 |
| House | Jan 6, 1999 | Jan 3, 2001 | CO-1 | Democrat | 106 |
| House | Jan 7, 1997 | Jan 3, 1999 | CO-1 | Democrat | 105 |
Sources: unitedstates/congress-legislators — legislators-current
| Bill | Title | Status |
|---|---|---|
| H.R. 3491 | DeOndra Dixon INCLUDE Project Act of 2025 | Passed the House |
| H.R. 10227 | INSULIN Act of 2026 | Introduced / in committee |
| H.R. 9392 | Medicare Advantage Cost Transparency Act | Introduced / in committee |
| H.Res. 1285 | Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. | Introduced / in committee |
| H.R. 8432 | To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes. | Introduced / in committee |
| H.R. 7425 | Colorado Wilderness Act of 2026 | Introduced / in committee |
| H.R. 7173 | Follow the Science Act | Introduced / in committee |
| H.R. 6082 | Fracturing Responsibility and Awareness of Chemicals Act of 2025 | Introduced / in committee |
| H.R. 5621 | Physical Therapist Workforce and Patient Access Act of 2025 | Introduced / in committee |
| H.R. 5461 | Special Diabetes Program Reauthorization Act of 2025 | Introduced / in committee |
| H.R. 4778 | For the relief of Jeanette Vizguerra-Ramirez. | Introduced / in committee |
| H.Res. 601 | Recognizing the duty of the Federal Government to lead the world in biomedical research. | Introduced / in committee |
“Key” = one rule for every member: final votes on measures that became law, were vetoed, or were decided by ≤ 5%; plus Cabinet and Supreme Court confirmations.
Sources: Office of the Clerk, U.S. House — roll call vote XML؛ GPO govinfo — BILLSTATUS bulk data, 119th Congress (same data as congress.gov)؛ Computed by this project from hvote/svote/bills using the rules in PLAN.md (phase 2) — as_of 2026-10-28
Determined after the Nov 3, 2026 election and certification; the 120th Congress convenes Jan 3, 2027
